I discuss genetic testing options and help the patient make a decision about the genetic testing that is best for them. I find it rewarding to educate patients and families about hereditary cancer risk so they can make informed and empowered decisions about their medical care.
Emily G. Wakefield, LGC

About

Biography

I’m a genetic counselor working with patients in the Hereditary Cancer Program. I also work as a laboratory genetic counselor in the Genetics and Genomics Diagnostic Laboratory.

In my Hereditary Cancer Program role, I meet adults with a personal or family history of cancer. I conduct a risk assessment to determine if inherited genetic changes could cause the type of cancer present. I discuss genetic testing options and help the patient make a decision about the genetic testing that is best for them. I find it rewarding to educate patients and families about hereditary cancer risk so they can make informed and empowered decisions about their medical care.

In my laboratory role, I help healthcare providers order genetic testing for their patients. I write genetic test reports, which help translate complex medical information into easy-to-understand information for providers and families.

When I’m not working, I like to spend time with my husband and daughter. I love baking, eating Mexican food, and watching the Great British Bake Off and true crime documentaries.

MS: Genetic Counseling, University of Alabama at Birmingham, 2014.

BS: Molecular Genetics, The Ohio State University, 2010.

Services and Specialties

Genetics

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Comparison of genetic testing documentation between genetic counselors and non-genetic counselors. Feldman, J; Bhimarao Nagaraj, C; Collins, K; Wakefield, E; He, H; Myers, M; Wusik, K. Journal of Genetic Counseling. 2023; 32:635-645.

Craniosynostosis is a feature of Costello syndrome. Weaver, KN; Care, M; Wakefield, E; Zarate, YA; Skoch, J; Gripp, KW; Prada, CE. American Journal of Medical Genetics, Part A. 2022; 188:1280-1286.

Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics. Menke, C; Nagaraj, CB; Dawson, B; He, H; Tawde, S; Wakefield, EG. Journal of Genetic Counseling. 2021; 30:1559-1569.

Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. Koczkowska, M; Callens, T; Gomes, A; Sharp, A; Chen, Y; Hicks, AD; Aylsworth, AS; Azizi, AA; Basel, DG; Bellus, G; et al. Genetics in Medicine. 2019; 21:867-876.

Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1. Kongkriangkai, AM; King, C; Martin, LJ; Wakefield, E; Prada, CE; Kelly-Mancuso, G; Schorry, EK. American Journal of Medical Genetics, Part A. 2019; 179:602-607.

Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy. Aljeaid, D; Isabel Sanchez, A; Wakefield, E; Chadwell, SE; Moore, N; Prada, CE; Zhang, W. American Journal of Medical Genetics, Part A. 2019; 179:608-614.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating